Angiotech Pharmaceuticals
Angiotech was a pharmaceutical company in Vancouver, British Columbia, Canada. Angiotech was founded in 1992 by William L. Hunter, Lindsay Machan, and Larry Arsenault. It sought to develop innovative technologies and medical products primarily for local diseases and complications associated with medical device implants, surgical interventions and acute injury. In April 2010, Angiotech acquired Haemacure manufacturing to develop human biological adhesives, hemostats and therapeutic proteins.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Angiotech Pharmaceuticals
Angiotech was a pharmaceutical company in Vancouver, British Columbia, Canada. Angiotech was founded in 1992 by William L. Hunter, Lindsay Machan, and Larry Arsenault. It sought to develop innovative technologies and medical products primarily for local diseases and complications associated with medical device implants, surgical interventions and acute injury. In April 2010, Angiotech acquired Haemacure manufacturing to develop human biological adhesives, hemostats and therapeutic proteins.
has abstract
Angiotech was a pharmaceutical ...... apital and China's ZQ Capital.
@en
industry
number of employees
Link from a Wikipage to an external page
Wikipage page ID
page length (characters) of wiki page
Wikipage revision ID
1,011,583,471
Link from a Wikipage to another Wikipage
homepage
industry
Pharmaceutical
@en
key people
K. Thomas Bailey
@en
location city
location country
name
Angiotech Pharmaceuticals Inc
@en
num employees
type
Public
@en
wikiPageUsesTemplate
subject
hypernym
comment
Angiotech was a pharmaceutical ...... tats and therapeutic proteins.
@en
label
Angiotech Pharmaceuticals
@en
closeMatch
wasDerivedFrom
homepage
isPrimaryTopicOf
name
Angiotech Pharmaceuticals Inc
@en